000 01253 a2200349 4500
005 20250513134819.0
264 0 _c19980227
008 199802s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1998.59
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHolford, J
245 0 0 _aIn vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
_h[electronic resource]
260 _bBritish journal of cancer
_c1998
300 _a366-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCisplatin
_xpharmacokinetics
650 0 4 _aDNA
_xmetabolism
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aGlutathione
_xmetabolism
650 0 4 _aHumans
650 0 4 _aOrganoplatinum Compounds
_xpharmacology
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Suppressor Protein p53
_xbiosynthesis
700 1 _aSharp, S Y
700 1 _aMurrer, B A
700 1 _aAbrams, M
700 1 _aKelland, L R
773 0 _tBritish journal of cancer
_gvol. 77
_gno. 3
_gp. 366-73
856 4 0 _uhttps://doi.org/10.1038/bjc.1998.59
_zAvailable from publisher's website
999 _c9441574
_d9441574